Safety of egg membrane collagen peptides as a novel food pursuant to Regulation (EU) 2015/2283

Dominique Turck; Torsten Bohn; Montaña Cámara; Jacqueline Castenmiller; Stefaan De Henauw; Ángeles Jos; Alexandre Maciuk; Inge Mangelsdorf; Breige McNulty; Androniki Naska; Kristina Pentieva; Alfonso Siani; Frank Thies; Margarita Aguilera-Gómez; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Francesca Marcon; Harry J McArdle; Peter Moldeus; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Alexandros Siskos; Henk van Loveren; Matt Wright; Reinhard Ackerl; Karen Ildico Hirsch-Ernst; EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)

doi:10.2903/j.efsa.2025.9709

Safety of egg membrane collagen peptides as a novel food pursuant to Regulation (EU) 2015/2283

Dominique Turck
, Torsten Bohn
, Montaña Cámara
, Jacqueline Castenmiller
, Stefaan De Henauw
, Ángeles Jos
, Alexandre Maciuk
, Inge Mangelsdorf
, Breige McNulty
, Androniki Naska
, Kristina Pentieva
, Alfonso Siani
, Frank Thies
, Margarita Aguilera-Gómez
, Francesco Cubadda
, Thomas Frenzel
, Marina Heinonen
, Francesca Marcon
, Harry J McArdle
, Peter Moldeus

Monika Neuhäuser-Berthold, Morten Poulsen, Miguel Prieto Maradona, Josef Rudolf Schlatter, Alexandros Siskos, Henk van Loveren, Matt Wright, Reinhard Ackerl, Karen Ildico Hirsch-Ernst, EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)

NutriHealth

Research output: Contribution to journal › Article › Research

Abstract

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on egg membrane collagen peptides as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is derived from farmed chicken eggs. It is produced by enzymatic hydrolysis, and it contains 15%-30% collagen peptides. The production process is sufficiently described and does not raise safety concerns. The applicant proposed to market the NF for use in food supplements for adults, excluding pregnant and lactating women, at a maximum daily dose of 500 mg. Taking into account the nature of the NF, the compositional data and information on the production process, the Panel considers that no toxicological studies are required for the NF. The Panel concludes that the NF, egg membrane collagen peptides, is safe under the proposed conditions of use.

Original language	English
Article number	e9709
Number of pages	12
Journal	EFSA Journal
Volume	23
Issue number	12
DOIs	https://doi.org/10.2903/j.efsa.2025.9709
Publication status	Published - 3 Dec 2025

Access to Document

10.2903/j.efsa.2025.9709Licence: CC BY-ND

Cite this

Turck, D., Bohn, T., Cámara, M., Castenmiller, J., De Henauw, S., Jos, Á., Maciuk, A., Mangelsdorf, I., McNulty, B., Naska, A., Pentieva, K., Siani, A., Thies, F., Aguilera-Gómez, M., Cubadda, F., Frenzel, T., Heinonen, M., Marcon, F., McArdle, H. J., ... EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) (2025). Safety of egg membrane collagen peptides as a novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal, 23(12), Article e9709. https://doi.org/10.2903/j.efsa.2025.9709

@article{bde8b85a96fa4d07b0134c6c725cfd74,

title = "Safety of egg membrane collagen peptides as a novel food pursuant to Regulation (EU) 2015/2283",

abstract = "Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on egg membrane collagen peptides as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is derived from farmed chicken eggs. It is produced by enzymatic hydrolysis, and it contains 15\%-30\% collagen peptides. The production process is sufficiently described and does not raise safety concerns. The applicant proposed to market the NF for use in food supplements for adults, excluding pregnant and lactating women, at a maximum daily dose of 500 mg. Taking into account the nature of the NF, the compositional data and information on the production process, the Panel considers that no toxicological studies are required for the NF. The Panel concludes that the NF, egg membrane collagen peptides, is safe under the proposed conditions of use.",

author = "Dominique Turck and Torsten Bohn and Monta{\~n}a C{\'a}mara and Jacqueline Castenmiller and \{De Henauw\}, Stefaan and {\'A}ngeles Jos and Alexandre Maciuk and Inge Mangelsdorf and Breige McNulty and Androniki Naska and Kristina Pentieva and Alfonso Siani and Frank Thies and Margarita Aguilera-G{\'o}mez and Francesco Cubadda and Thomas Frenzel and Marina Heinonen and Francesca Marcon and McArdle, \{Harry J\} and Peter Moldeus and Monika Neuh{\"a}user-Berthold and Morten Poulsen and \{Prieto Maradona\}, Miguel and Schlatter, \{Josef Rudolf\} and Alexandros Siskos and \{van Loveren\}, Henk and Matt Wright and Reinhard Ackerl and Hirsch-Ernst, \{Karen Ildico\} and \{EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)\}",

note = "{\textcopyright} 2025 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority.",

year = "2025",

month = dec,

day = "3",

doi = "10.2903/j.efsa.2025.9709",

language = "English",

volume = "23",

journal = "EFSA Journal",

issn = "1831-4732",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "12",

}

Turck, D, Bohn, T, Cámara, M, Castenmiller, J, De Henauw, S, Jos, Á, Maciuk, A, Mangelsdorf, I, McNulty, B, Naska, A, Pentieva, K, Siani, A, Thies, F, Aguilera-Gómez, M, Cubadda, F, Frenzel, T, Heinonen, M, Marcon, F, McArdle, HJ, Moldeus, P, Neuhäuser-Berthold, M, Poulsen, M, Prieto Maradona, M, Schlatter, JR, Siskos, A, van Loveren, H, Wright, M, Ackerl, R, Hirsch-Ernst, KI & EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2025, 'Safety of egg membrane collagen peptides as a novel food pursuant to Regulation (EU) 2015/2283', EFSA Journal, vol. 23, no. 12, e9709. https://doi.org/10.2903/j.efsa.2025.9709

TY - JOUR

T1 - Safety of egg membrane collagen peptides as a novel food pursuant to Regulation (EU) 2015/2283

AU - Turck, Dominique

AU - Bohn, Torsten

AU - Cámara, Montaña

AU - Castenmiller, Jacqueline

AU - De Henauw, Stefaan

AU - Jos, Ángeles

AU - Maciuk, Alexandre

AU - Mangelsdorf, Inge

AU - McNulty, Breige

AU - Naska, Androniki

AU - Pentieva, Kristina

AU - Siani, Alfonso

AU - Thies, Frank

AU - Aguilera-Gómez, Margarita

AU - Cubadda, Francesco

AU - Frenzel, Thomas

AU - Heinonen, Marina

AU - Marcon, Francesca

AU - McArdle, Harry J

AU - Moldeus, Peter

AU - Neuhäuser-Berthold, Monika

AU - Poulsen, Morten

AU - Prieto Maradona, Miguel

AU - Schlatter, Josef Rudolf

AU - Siskos, Alexandros

AU - van Loveren, Henk

AU - Wright, Matt

AU - Ackerl, Reinhard

AU - Hirsch-Ernst, Karen Ildico

AU - EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)

PY - 2025/12/3

Y1 - 2025/12/3

N2 - Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on egg membrane collagen peptides as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is derived from farmed chicken eggs. It is produced by enzymatic hydrolysis, and it contains 15%-30% collagen peptides. The production process is sufficiently described and does not raise safety concerns. The applicant proposed to market the NF for use in food supplements for adults, excluding pregnant and lactating women, at a maximum daily dose of 500 mg. Taking into account the nature of the NF, the compositional data and information on the production process, the Panel considers that no toxicological studies are required for the NF. The Panel concludes that the NF, egg membrane collagen peptides, is safe under the proposed conditions of use.

AB - Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on egg membrane collagen peptides as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is derived from farmed chicken eggs. It is produced by enzymatic hydrolysis, and it contains 15%-30% collagen peptides. The production process is sufficiently described and does not raise safety concerns. The applicant proposed to market the NF for use in food supplements for adults, excluding pregnant and lactating women, at a maximum daily dose of 500 mg. Taking into account the nature of the NF, the compositional data and information on the production process, the Panel considers that no toxicological studies are required for the NF. The Panel concludes that the NF, egg membrane collagen peptides, is safe under the proposed conditions of use.

UR - https://pubmed.ncbi.nlm.nih.gov/41346947/

U2 - 10.2903/j.efsa.2025.9709

DO - 10.2903/j.efsa.2025.9709

M3 - Article

C2 - 41346947

SN - 1831-4732

VL - 23

JO - EFSA Journal

JF - EFSA Journal

IS - 12

M1 - e9709

ER -

Safety of egg membrane collagen peptides as a novel food pursuant to Regulation (EU) 2015/2283

Abstract

Access to Document

Other files and links

Fingerprint

Cite this